SCHEMBL27076138

SCHEMBL27076138

COc1cc(C2=CCNCC2)c(C)cc1Nc1ncc(Br)c(Nc2ccc3nccnc3c2NS(C)(=O)=O)n1

nearest known ligand 0.55

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ ALK Q9UM73 3/20 0.55
▸ EGFR P00533 17/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30015241 1.00 ALK (0.55) ALKEGFR
SCHEMBL27076120 0.84 ALK (0.63) ALKEGFR
SCHEMBL27076019 0.80 EGFR (0.74) ALKEGFR
SCHEMBL27091449 0.80 EGFR (0.67) EGFR
SCHEMBL29785241 0.80 EGFR (0.67) EGFR
SCHEMBL27076043 0.79 EGFR (0.61) EGFR
SCHEMBL30014899 0.79 EGFR (0.61) EGFR
SCHEMBL29785289 0.78 EGFR (0.69) EGFR
SCHEMBL27091451 0.78 EGFR (0.69) EGFR
SCHEMBL31204484 0.78 EGFR (0.60) EGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4313969-A1 N2-PHENYLPYRIMIDINE-2,4-DIAMINE COMPOUNDS, AND PREPARATION METHODS AND METHODS OF USE THEREOF Bridge Biotherapeutics, Inc. (KR) 2024-02-07 — — EP disclosed
CN-117203199-A N2-phenylpyrimidine-2, 4-diamine compounds, methods of making and using the same 毕利吉生物科技股份有限公司 2023-12-08 — — CN disclosed
Send feedback